Literature DB >> 15033884

Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors.

Martin Bornhäuser, Rainer Schwerdtfeger, Hilmar Martin, Karl-Heinz Frank, Catrin Theuser, Gerhard Ehninger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15033884     DOI： 10.1182/blood-2003-11-3893

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  36 in total

1.  The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.

Authors:  Hongbo Wang; Bartosz Grzywacz; David Sukovich; Valarie McCullar; Qing Cao; Alisa B Lee; Bruce R Blazar; David N Cornfield; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

Review 2.  Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.

Authors:  Loredana Ruggeri; Marusca Capanni; Antonella Mancusi; Katia Perruccio; Emanuela Burchielli; Massimo F Martelli; Andrea Velardi
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

3.  NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Authors:  Andreas T Björklund; Marie Schaffer; Cyril Fauriat; Olle Ringdén; Mats Remberger; Christina Hammarstedt; A John Barrett; Per Ljungman; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-01-22       Impact factor: 22.113

Review 4.  Can we make a better match or mismatch with KIR genotyping?

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 5.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

6.  The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).

Authors:  M D Keller; D F Chen; S A Condron; N Liu; N L Reinsmoen; R H Buckley
Journal:  J Clin Immunol       Date:  2006-12-27       Impact factor: 8.317

7.  Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.

Authors:  Jumei Shi; Guido Tricot; Susann Szmania; Nancy Rosen; Tarun K Garg; Priyangi A Malaviarachchi; Amberly Moreno; Bo Dupont; Katharine C Hsu; Lee Ann Baxter-Lowe; Michele Cottler-Fox; John D Shaughnessy; Bart Barlogie; Frits van Rhee
Journal:  Br J Haematol       Date:  2008-10-16       Impact factor: 6.998

8.  KIR Donor Selection: Feasibility in Identifying better Donors.

Authors:  Daniel Weisdorf; Sarah Cooley; Tao Wang; Elizabeth Trachtenberg; Michael D Haagenson; Cynthia Vierra-Green; Stephen Spellman; Ashley Spahn; Jenny Vogel; Hati Kobusingye; Todd Fehninger; Ann Woolfrey; Steven Devine; Maureen Ross; Edmund K Waller; Ronald Sobecks; Peter Parham; Lisbeth A Guethlein; Steven G E Marsh; Jeffrey Miller
Journal:  Biol Blood Marrow Transplant       Date:  2018-08-24       Impact factor: 5.742

Review 9.  Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

Authors:  Amanda K Purdy; Kerry S Campbell
Journal:  Cancer Biol Ther       Date:  2009-12-28       Impact factor: 4.742

Review 10.  Current status of haploidentical stem cell transplantation for leukemia.

Authors:  Xiao-jun Huang
Journal:  J Hematol Oncol       Date:  2008-12-31       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.